ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL2962 |
|
1609392-27-9 |
Deucravacitinib | BMS-986165 99+% |
C20H19D3N8O3 | |
CL2956B |
|
1092939-16-6 |
Ruxolitinib sulfate | INCB018424 sulfate 98+% |
C17H18N6 · H2SO4 | |
CL2956A |
|
1092939-17-7 |
Ruxolitinib phosphate| INCB-018424 phosphate 98+% |
C17H18N6·H3PO4 | |
CL2956 |
|
941678-49-5 |
Ruxolitinib | INCB018424 | Ruxolitinib Free base | (R)-Ruxolitinib 98+% |
C17H18N6 | |
CL2949 |
|
1229236-86-5 |
Gandotinib | LY2784544 98+% |
C23H25ClFN7O | |
CL2918 |
|
1622902-68-4 |
Abrocitinib | PF-04965842 | N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide | N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}-propane-1-sulfonamide 98+% |
C14H21N5O2S | |
CL2884 |
|
936091-14-4 |
TG101209 98+% |
C26H35N7O2S | |
CL2247A |
|
2050057-56-0 |
Upadacitinib hemihydrate 98+% |
C34H40F6N12O3 | |
CL2693 |
|
1792180-81-4 |
Ritlecitinib 98+% |
C15H19N5O | |
CL2693A |
|
2192215-81-7 |
Ritlecitinib Tosylate 98+% |
C22H27N5O4S | |
CL2655 |
|
1263774-59-9 |
Delgocitinib | JTE-052 | Corectim 98+% |
C16H18N6O | |
CL2547 |
|
83280-65-3 |
Napabucasin(BBI608) 98+% |
C14H8O4 | |
CL2531 |
|
1640292-55-2 |
Oclacitinib Maleate (PF-03394197 Maleate) 98+% |
C19H27N5O6S | |
CL1014B |
|
485-19-8 |
Reticuline 98+% |
C19H23NO4 | |
HL1389 |
|
88495-63-0 |
Artesunate 98+% |
C19H28O8 | |
CL1528 |
|
1025065-69-3 |
SGI-1776 free base 98+% |
C20H22F3N5O | |
CL1888 |
|
936091-26-8 |
Fedratinib | TG-101348 | SAR 302503 98+% |
C27H36N6O3S | |
CL2247 |
|
1310726-60-3 |
ABT-494(Upadacitinib) Free base 95% |
C₁₇H₁₉F₃N₆O | |
CL1120A |
|
540737-29-9 |
Tofacitinib Citrate | Tasocitinib Citrate | CP-690550 Citrate 98+% |
C16H20N6O.C6H8O7 | |
CL1120 |
|
477600-75-2 |
Tofacitinib | Tasocitinib | CP-690550 98+% |
C16H20N6O | |